News Column

InSite Vision to Webcast Annual Meeting of Stockholders on July 16, 2014

July 15, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)-- InSite Vision Incorporated (OTCBB: INSV) will hold its Annual Meeting of Stockholders at 10:00 a.m. Pacific Time on Wednesday, July 16, 2014 at the company's headquarters at 965 Atlantic Avenue, Alameda, California. Company management will host a live webcast of the meeting, including a corporate presentation, available on the Investor Relations page of the company's website ( For those who miss the live broadcast, an archived replay will be available shortly thereafter.

Analysts and investors can listen to the Annual Meeting via conference call by dialing 866-515-2911 for domestic callers and 617-399-5125 for international callers and entering the pass code 98634471.

About InSite Vision

InSite Vision is advancing new ophthalmologic products for unmet eye care needs based on its innovative DuraSite platform technologies. The DuraSite and DuraSite 2 drug delivery systems extend the duration of drug retention on the surface of the eye, thereby reducing the frequency of treatment and improving the efficacy of topical drugs.

The DuraSite platform is currently leveraged in two commercial products for the treatment of bacterial eye infections, AzaSite (azithromycin ophthalmic solution) 1%, marketed in the U.S. by Akorn Inc.; and Besivance (besifloxacin ophthalmic suspension) 0.6%, marketed by Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International. InSite Vision is also advancing AzaSite Plus, a novel ophthalmic therapeutics through Phase 3 clinical studies for the treatment of eye infections, and is preparing two new drug applications (NDA) for the commercial approval by the U.S. Food & Drug Administration (FDA): BromSite for the treatment of inflammation and prevention of pain associated with cataract surgery and DexaSite for the treatment of blepharitis. For further information on InSite Vision, please visit

InSite Vision

Louis Drapeau, 510-747-1220

Chief Financial Officer


Media and Investor inquiries

BCC Partners

Michelle Corral, 415-794-8662

Karen L. Bergman, 650-575-1509

Source: InSite Vision Incorporated

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Business Wire

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters